RxSight (RXST) Interest Coverage Ratio (2020 - 2026)
RxSight's (RXST) quarterly Interest Coverage Ratio came in at 4600.0 in Q2 2026, down 64.25% on a YoY basis from 12867.32 in Q2 2025, and up 22.6% quarter-over-quarter from 5943.0 in Q1 2026.
Powered by 
Analysis
RxSight (RXST) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
RxSight (RXST) has reported Interest Coverage Ratio for 7 consecutive years, with 4600.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Interest Coverage Ratio fell 64.25% year-over-year to 4600.0; the trailing twelve-month figure through Jun 2026 stood at 3675.27 (down 264.08% YoY), and the FY2025 full-year result was 2536.84, down 44.37% from the prior year.
- Interest Coverage Ratio rose to 4600.0 in Q2 2026 per RXST's latest filing, from 5943.0 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 1783.33 in Q1 2024 and bottomed at 5943.0 in Q1 2026.
- Historically, Interest Coverage Ratio has averaged 1266.36 across 5 years, with a median of 721.62 in 2024.
- The sharpest annual moves came in 2023 and 2024: Interest Coverage Ratio plunged 26197.56% in 2023, then soared 20415.14% in 2024.
- Over 5 years, Interest Coverage Ratio stood at 10.33 in 2022, then plunged by 26197.56% to 2716.75 in 2023, then surged by 36.17% to 1734.0 in 2024, then sank by 30.33% to 2260.0 in 2025, then sank by 103.54% to 4600.0 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 4600.0, 5943.0, and 2260.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 4.82 |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 9.48 |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 11.77 |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 12.27 |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 0.21 |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 18.09 |
| 10 | RxSight | 265.13 Mn | -139.12 Mn | - | -4,600.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4,600.00 |
| Mar 31, 2026 | -5,943.00 |
| Dec 31, 2025 | -2,260.00 |
| Sep 30, 2025 | -3,050.00 |
| Jun 30, 2025 | -2,800.60 |
| Mar 31, 2025 | 1,783.33 |
| Dec 31, 2024 | -1,734.00 |
| Sep 30, 2024 | -1,845.20 |
| Jun 30, 2024 | -1,388.83 |
| Mar 31, 2024 | 1,783.33 |
| Dec 31, 2023 | -2,716.75 |
| Sep 30, 2023 | -54.40 |
| Jun 30, 2023 | -8.69 |
| Mar 31, 2023 | 8.69 |
| Dec 31, 2022 | -10.33 |
| Sep 30, 2022 | 12.32 |
| Jun 30, 2022 | 13.91 |
| Mar 31, 2022 | 15.66 |
| Dec 31, 2021 | 84.27 |
| Sep 30, 2021 | -12.15 |